1-((Dimethylamino)methyl)cyclopropanecarboxylic acid

Catalog No.: 
ACSONG234
CAS No.: 
633335-75-8
Molecular Formula: 
C7H13NO2
Molecular Weight: 
143.19
1-((Dimethylamino)methyl)cyclopropanecarboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$68.00In stockInquiry
100mg98%$115.00In stockIn stock
250mg98%$207.00In stockIn stock
1g98%$557.00In stockIn stock
5g98%$2527.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((Dimethylamino)methyl)cyclopropanecarboxylic acid
IUPAC Name1-((Dimethylamino)methyl)cyclopropanecarboxylic acid
MDL No.MFCD13249511
Molecular FormulaC7H13NO2
Molecular Weight143.19
SMILESO=C(C1(CN(C)C)CC1)O
InChI KeyIAQPYMSFAIDGFT-UHFFFAOYSA-N
SynonymCyclopropanecarboxylic acid, 1-[(dimethylamino)methyl]- (9CI);Cyclopropanecarboxylic acid, 1-[(dimethylamino)methyl]-;1-((Dimethylamino)methyl)cyclopropanecarboxylic acid
CAS No.633335-75-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSONG234 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSONG234 route product structure diagram
    ACSONG234633335-75-8In Stock
Inquiry

2. ACSONG234 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSONG234 route product structure diagram
    ACSONG234633335-75-8In Stock
Inquiry

3. ACSONG234 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSONG234 route product structure diagram
    ACSONG234633335-75-8In Stock
Inquiry

Comments (0)